Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

BACKGROUND: Concomitant medications, such as steroids, proton pump inhibitors (PPI) and antibiotics, might affect clinical outcomes with immune checkpoint inhibitors. METHODS: We conducted a multicenter observational retrospective study aimed at evaluating the impact of concomitant medications on cl...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Cortellini, Alessio, Tucci, Marco, Adamo, Vincenzo, Stucci, Luigia Stefania, Russo, Alessandro, Tanda, Enrica Teresa, Spagnolo, Francesco, Rastelli, Francesca, Bisonni, Renato, Santini, Daniele, Russano, Marco, Anesi, Cecilia, Giusti, Raffaele, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Gelibter, Alain, Occhipinti, Mario Alberto, Marconcini, Riccardo, Vitale, Maria Giuseppa, Nicolardi, Linda, Chiari, Rita, Bareggi, Claudia, Nigro, Olga, Tuzi, Alessandro, De Tursi, Michele, Petragnani, Nicola, Pala, Laura, Bracarda, Sergio, Macrini, Serena, Inno, Alessandro, Zoratto, Federica, Veltri, Enzo, Di Cocco, Barbara, Mallardo, Domenico, Vitale, Maria Grazia, Pinato, David James, Porzio, Giampiero, Ficorella, Corrado, Ascierto, Paolo Antonio
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: BMJ Publishing Group 2020
Aiheet:
Clinical/Translational Cancer Immunotherapy
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646355/
https://www.ncbi.nlm.nih.gov/pubmed/33154150
http://dx.doi.org/10.1136/jitc-2020-001361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646355/
https://www.ncbi.nlm.nih.gov/pubmed/33154150
http://dx.doi.org/10.1136/jitc-2020-001361

Samankaltaisia teoksia